Showing results (1-10 of 460) with videos related to
Sort By:
Pageof 46
Expert Opinion on Pharmacotherapy|November 5, 2015
Advancing pharmacotherapy for treating Huntington's disease: a review of the existing literatureSarah L Mason, Roger A BarkerExpert Opinion on Emerging Drugs|May 21, 2009
Emerging drug therapies in Huntington's diseaseSarah L Mason, Roger A BarkerDegenerative Neurological and Neuromuscular Disease|July 28, 2018
Novel targets for Huntington's disease: future prospectsSarah L Mason, Roger A BarkerJournal of Huntington'S Disease|July 18, 2020
The Clinical Features and Progression of Late-Onset Versus Younger-Onset in an Adult Cohort of Huntington's Disease PatientsMegha Anil, Sarah L Mason, Roger A BarkerBrain Sciences|July 2, 2021
Problems with Social Cognition and Decision-Making in Huntington's Disease: Why Is it Important?Sarah L Mason, Miriam Schaepers, Roger A BarkerProgress in Brain Research|December 1, 2012
Current status of clinical trials of neural transplantation in Parkinson's diseaseJonathan R Evans, Sarah L Mason, Roger A BarkerJournal of Neurology|February 15, 2022
Exploring the predictors of financial impairment in Huntington's disease using the Enroll-HD datasetKate L Harris, Sarah L Mason, Roger A BarkerNeurorehabilitation|February 11, 2020
Parkinson's disease and spiritualityClare Redfern, Sarah L Mason, Roger A Barker, et al.The Lancet. Neurology|December 15, 2012
Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's diseaseRoger A Barker, Jessica Barrett, Sarah L Mason, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 3, 2016
Hippocampal dysfunction defines disease onset in Huntington's diseaseFaye Begeti, Laetitia C Schwab, Sarah L Mason, et al.Pageof 46